The use of duloxetine in chronic bulimia nervosa: a case report.
Selective serotonin reuptake inhibitors are routinely prescribed as off-label treatments for bulimia nervosa. There is, however, a paucity of literature addressing the efficacy of the serotonin norepinephrine reuptake inhibitors in the pharmacologic management of this disorder. This article describes a clinical situation in which duloxetine, a serotonin norepinephrine reuptake inhibitor, effectively treated a patient with long-standing bulimia nervosa, purging type, and comorbid generalized anxiety disorder.
Christensen
Richard C
RC
Dr. Christensen is Professor and Chief of the Division of Public Psychiatry at the University of Florida College of Medicine.
Averbuch
Robert N
RN